|
Volcano Corporation
Announces Webcast of February 25th Analyst Day
|
 |
 |
|
February
20, 2009, San Diego -- Volcano Corporation
(Nasdaq: VOLC), a leader in the development, manufacturing
and sales of products for the diagnosis and treatment of
coronary and peripheral artery disease, will hold its 2009
Analyst Day on Wednesday, February 25, at the NASDAQ MarketSite
in New York City. |
The webcast will begin at 10 a.m., Eastern Standard
Time (7 a.m., Pacific Standard Time) and conclude at 2 p.m., Eastern
Standard Time (11 a.m., Pacific Standard Time).
The webcast of the event will be available through
Volcano's website on the webcasts and presentations page of the
investor relations section at http://www.volcanocorp.com.
If you would like additional information about
the event, please contact Neal B. Rosen at (415) 692-3058.
Volcano Corporation (NASDAQ: VOLC) offers a broad
suite of devices designed to facilitate endovascular procedures,
enhance the diagnosis of
vascular and structural heart disease and guide optimal therapies.
The company's
intravascular ultrasound (IVUS) product line includes ultrasound
consoles that can be integrated directly into virtually any
modern cath lab. Volcano IVUS offers unique features, including
both
single-use phased array and rotational IVUS imaging catheters,
and advanced
functionality options, such as VH(R) IVUS tissue characterization
and ChromaFlo(R). Volcano also provides functional measurement
(FM) consoles and single-use pressure and flow guide wires
and is developing a line of ultra-high resolution Optical Coherence
Tomography (OCT) systems and catheters. Currently, more than
4,000 Volcano IVUS and FM systems are installed worldwide, with
approximately
half of its revenues coming from outside the United States.
For
more information, visit the company's website at http://www.volcanocorp.com.
Source: Volcano Corporation
|
